Chemotherapy has significantly increased the number of cancer survivors. However,
chemotherapy itself carries various adverse effects that limit the efficacy of treatment and …

Many cancer patients treated with chemotherapy develop chemotherapy-induced cognitive
impairment (CICI), often referred to as chemo-brain, which manifest during or post-treatment …

Chemobrain refers to a common sequela experienced by a substantial subset of cancer
patients exposed to chemotherapeutic treatment, a phenomenon that dramatically …

To review the domains of cognitive function and their corresponding neuroanatomic
structures as well as present current evidence for neurotoxicity associated with specific …

For some cancer survivors chemotherapy treatment is associated with lasting cognitive
impairment, long after treatment cessation. Several candidate mechanisms have been …

The potentially detrimental effects of cancer and related treatments on cognitive functioning
are emerging as a key focus of cancer survivorship research. Many patients with central …

Cognitive impairment is a potential long-term side effect of adjuvant chemotherapy that can
have a major impact on the quality of life of cancer survivors. There is a growing number of …

The term chemotherapy-related cognitive impairment (CRCI), or cognitive dysfunction, or
chemo fog, or chemo brain, is referred to a decline in a variety of neuropsychological tasks …

Chemotherapy can improve prospects for long-term survival after a cancer diagnosis, but it
may also be associated with long-term toxicity, including the possibility of cognitive …

Recent studies have indicated the frequent occurrence of neuropsychologic deficits and
cognitive complaints after systemic cancer chemotherapy. Most early reports were …